Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Galderma Group AG - Unsponsored ADR (GALDY : OTC)

• Company Description    Galderma Group AG operates as a dermatology company. It delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare and therapeutic dermatology. Galderma Group AG is based in Zug, Switzerland. Number of Employees: 7,676

• Price / Volume Information    Yesterday's Closing Price: $40.55 Daily Weekly Monthly 20 Day Moving Average: 140,263 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $44.06 52 Week Low: $23.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.92% -1.52% 12 Week 1.38% -7.27% Year To Date -2.17% -10.72%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Zahlerweg 10 - Zug,V8 6300 CHE ph: 41-58-455-8592 fax: - investors@galderma.com http://www.galderma.com

• General Corporate Information    Officers Flemming ?rnskov - Chief Executive Officer Thomas Ebeling - Chairman Sherilyn McCoy - Vice Chairman Thomas Dittrich - Chief Financial Officer Michael Bauer - Director Peer Information Galderma Group AG - Unsponsored ADR (BJCT) Galderma Group AG - Unsponsored ADR (CADMQ) Galderma Group AG - Unsponsored ADR (APNO) Galderma Group AG - Unsponsored ADR (UPDC) Galderma Group AG - Unsponsored ADR (IMTIQ) Galderma Group AG - Unsponsored ADR (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 36321W105 SIC: - Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 06/04/26 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.25 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.98 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 04/27/2026 - $0.00 Next EPS Report Date: 06/04/26

• Fundamental Ratios P/E Current FY Estimate: 41.38 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - 1.19 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - 0.93 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - 12.17 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - - 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - 3.18 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.33 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - 24.81 09/30/25 - -

Powered by Zacks Investment Research ©